The FDA named nine drugs for accelerated review under a new “national interest” program, including treatments for vaping addiction, deafness, and infertility. Trump touted the move to lower IVF costs as the agency fast-tracks approvals.
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02The Food and Drug Administration announced nine experimental drugs Thursday that were able to receive accelerator reviews on our new program prioritizing medicines labeled as supporting U.S. national interests, according to the AP.
00:13This includes potential treatments for vaping addiction, deafness, and pancreatic cancer.
00:16Trump highlighted Pergoveris, an infertility drug used in Europe, saying approval of lower IVF costs for American families.
00:23Another company received an expedited review to expand U.S. ketamine production.
00:27The FDA plans to decide on drug approvals within one to two months, an unprecedented speed for its detailed safety and efficacy reviews.
00:35The new national priority voucher program overlaps with older initiatives but grants FDA officials broad discretion in selecting companies for accelerator reviews.
Be the first to comment